Post-approval studies (Phase 4)Active Not RecruitingNCT02616666
What this trial is testing
A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients
Who this might be right for
Type 2 Diabetes Mellitus
University of Liverpool 632